Comment
doi: 10.1016/S0140-6736(09)62132-2.
Epub 2009 Dec 15.
Large trials confirm immunogenicity of H1N1 vaccines
Affiliations
- PMID: 20018366
- DOI: 10.1016/S0140-6736(09)62132-2
Item in Clipboard
Comment
Large trials confirm immunogenicity of H1N1 vaccines
Lancet.
.
No abstract available
Comment on
-
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.Lancet. 2010 Jan 2;375(9708):56-66. doi: 10.1016/S0140-6736(09)62003-1. Epub 2009 Dec 15. Lancet. 2010. PMID: 20018364 Clinical Trial.
-
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.Lancet. 2010 Jan 2;375(9708):41-8. doi: 10.1016/S0140-6736(09)62026-2. Epub 2009 Dec 15. Lancet. 2010. PMID: 20018365 Clinical Trial.
-
Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.Lancet. 2010 Jan 2;375(9708):49-55. doi: 10.1016/S0140-6736(09)62039-0. Epub 2009 Dec 15. Lancet. 2010. PMID: 20018367 Clinical Trial.
Similar articles
-
[Serological survey of pandemic influenza A (H1N1) virus infection among population in Hunan Province].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Feb;25(1):17-9. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011. PMID: 21789845 Chinese.
-
Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.Vaccine. 2012 Jul 13;30(33):5030-7. doi: 10.1016/j.vaccine.2012.03.053. Epub 2012 Apr 1. Vaccine. 2012. PMID: 22472791 Clinical Trial.
-
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.Vaccine. 2012 Jun 22;30(30):4543-51. doi: 10.1016/j.vaccine.2012.03.061. Epub 2012 Apr 1. Vaccine. 2012. PMID: 22475864 Clinical Trial.
-
Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations.Expert Rev Vaccines. 2011 Mar;10(3):365-75. doi: 10.1586/erv.10.172. Expert Rev Vaccines. 2011. PMID: 21434804 Review.
-
Live attenuated intranasal influenza vaccine.Hum Vaccin Immunother. 2012 Jan;8(1):76-80. doi: 10.4161/hv.8.1.18809. Epub 2012 Jan 1. Hum Vaccin Immunother. 2012. PMID: 22251995 Review.
Cited by
-
Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.Ther Adv Vaccines Immunother. 2019 Feb 7;7:2515135519826481. doi: 10.1177/2515135519826481. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 30793097 Free PMC article. Review.
-
Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.J Virol. 2011 Mar;85(6):2695-702. doi: 10.1128/JVI.02371-10. Epub 2011 Jan 12. J Virol. 2011. PMID: 21228239 Free PMC article.
-
Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.Influenza Other Respir Viruses. 2013 Sep;7(5):729-37. doi: 10.1111/irv.12018. Epub 2012 Oct 19. Influenza Other Respir Viruses. 2013. PMID: 23078073 Free PMC article.
-
Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.PLoS One. 2011;6(9):e24384. doi: 10.1371/journal.pone.0024384. Epub 2011 Sep 6. PLoS One. 2011. PMID: 21915319 Free PMC article.
-
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.BMJ. 2010 May 27;340:c2649. doi: 10.1136/bmj.c2649. BMJ. 2010. PMID: 20508026 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
